Could a bone drug help save hearing in brittle bone disease?
NCT ID NCT04152551
Summary
This study is testing if a common bone-strengthening drug (bisphosphonate) can help treat hearing loss in people with Osteogenesis Imperfecta (OI), also known as brittle bone disease. The drug will be given to 100 adults and children with OI to see if it can slow down or improve their hearing over five years. Researchers are doing this because the drug has helped a similar type of hearing loss in people without OI.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOGENESIS IMPERFECTA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital for Special Surgery
RECRUITINGNew York, New York, 10021, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.